Stay updated with breaking news from Bleeding Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BE-101 is Company’s Lead Program in Hemophilia B; IND Filing Anticipated in Mid-2024Be Bio Appoints Glenn Pierce, M.D., Ph.D., Hemophilia Physician-Researcher and Advocate, to its Scientific Advisory BoardPreclinical Study Findings Shared in Oral Presentation During 65th Annual Meeting of the American Society of Hem...
TEMECULA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises Inc. announces its 2023...
There is plenty to do this weekend -- plus it's the first weekend of the N.C. State Fair!
A commentary questions the characterization of cryoprecipitate, which is not pathogen-reduced, as an alternative modality for treating hemophilia, despite its substantial risk of transmitting blood-borne pathogens to patients.